VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
173 hedge funds and large institutions have $364M invested in Verve Therapeutics in 2024 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
+7
Holders Change %
+4.22%
% of All Funds
2.5%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
33
Increased
62
Reduced
46
Closed
25
Calls
$414K
Puts
$1.19M
Net Calls
-$771K
Net Calls Change
-$343K
Top Buyers
| 1 |
SSA
1
Schonfeld Strategic Advisors
New York
|
$11.7M |
| 2 |
2
Millennium Management
New York
|
$24M |
| 3 |
CC
3
Casdin Capital
New York
|
$19.3M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$20.6M |
| 5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$8.09M |
